Skip to main content
Log in

Anti-inflammatory/anti-pyretic salicylic acid esters with low gastric ulcerogenic activity

  • Immunosuppression and Inflammation
  • Published:
Agents and Actions Aims and scope Submit manuscript

Abstract

The methyl and some other esters of acetylsalicylic and salicylic acids and their derivatives were found to have much lower gastric ulcerogenic activity (when assayed in the stress-sensitized rat) compared with their corresponding acids. There was little or no loss in therapeutic potencies of these salicylate esters as determined by assessment of anti-inflammatory activity (against the carrageenan-induced oedema) and antipyretic activity (against yeast-induced fever in rats. The methyl ester of acetylsalicylic acid (=AME) was almost devoid of gastric irritancy/ulcerogenicity (as observed with acetylsalicylic acid) when given orally to pigs for 10 days. AME had appreciable anti-inflammatory activity in the adjuvant-arthritis model and at high doses (200 mg/kg t.i.d.) was without the lethal effects seen with acetylsalicylic acid. Moreover, no toxic effects were seen after long-term administration of 100–1000 mg/kg/day AME for 3–4 months.

The results provide further evidence for the hypothesis that the carboxylic acid moiety of salicylates is a major factor in the gastric ulcerogenic activity of these drugs. The methyl esters of these salicylates may be considered as models for the development of pro-drugs and in some cases may be therapeutic alternatives to acetylsalicylic acid or salicylate.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. P.M. Brooks andW.W. Buchanan, in:Current Management of Rheumatoid Arthritis (Eds. W.W. Buchanan and W.C. Dick; Churchill Livingstone, Edinburgh 1976), p. 33.

    Google Scholar 

  2. A.R. Cooke,Drugs and Gastric Damage, Drugs11, 36–44 (1976).

    PubMed  Google Scholar 

  3. J.R. Leonards,Are All Aspirins Really Alike?, Aust. N.Z.J. Med.6 (suppl. 1), 8 (1976).

    Google Scholar 

  4. J.M. Grumpel,Incidence of Gastric Side-Effects in Controlled Trials with Unbranded Aspirin and with Various Long-Acting Aspirin Preparations, Ann. Rheum. Dis.37, 389 (1978).

    Google Scholar 

  5. K.D. Rainsford,Is the Radiochromium-Red Cell Technique a Valid Method for Measuring Gastrointestinal Blood Loss or Damage Following Aspirin Administration? Drugs expt Clin. Res.4, 183–189 (1978).

    Google Scholar 

  6. K.D. Rainsford andM.W. Whitehouse,Non-Steroid Anti-Inflammatory Drugs: Combined Assay for Anti-Edemic Potency and Gastric Ulcerogenesis in the Same Animal, Life Sciences21, 371–378 (1977).

    Article  PubMed  Google Scholar 

  7. K.D. Rainsford andM.W. Whitehouse,Are All Aspirins Alike? A Comparison of Gastric Ulcerogenicity with Bio-Efficacy in Rats, Pharmac. Res. Commun.12, 85–95 (1980).

    Google Scholar 

  8. K.D. Rainsford,Gastric Mucosal Ulceration Induced by Tablets but not Suspensions or Solutions of Aspirin in Pigs, J. Pharm. Pharmac.30, 129–131 (1978).

    Google Scholar 

  9. M.W. Whitehouse andK.D. Rainsford,Side-Effects of Anti-Inflammatory Drugs: Are they Essential or can they be Circumvented?, in:Inflammation Mechanisms and their Impact on Therapy (Eds. I.L. Bonta, J. Thompson, and K. Brune; Agents and Actions. Suppl. 3, Birkhäser. Basel 1977), pp. 171–187.

    Google Scholar 

  10. K.D. Rainsford andM.W. Whitehouse,Gastric Irritancy of Aspirin and its Congeners: Anti-Inflammatory Activity Without this Side-Effect. J. Pharm. Pharmac.28, 599–601 (1976).

    Google Scholar 

  11. K.D. Rainsford,A Synergistic Interaction Between Aspirin or Other Non-Steroid Anti-Inflammatory Drugs and Stress which produces Severe Gastric Mucosal Damage in Rats and Pigs, Agents and Actions5, 553–558 (1975).

    Google Scholar 

  12. K.D. Rainsford,Towards Assays of Gastro Intestinal Toxicity of Non-Steroid Anti-Inflammatory Drugs with Improved Predictive Value in Man, Agents and Actions7, 245–248 (1977).

    PubMed  Google Scholar 

  13. K.D. Rainsford,The Role of Aspirin in Gastric Ulceration. Some Factors Involved in the Development of Gastric Mucosal Damage Induced by Aspirin in Rats Exposed to Various Stress Conditions, Am. J. dig. Dis.23, 521–530 (1978).

    Article  PubMed  Google Scholar 

  14. M.W. Whitehouse, K.J. Orr, F.J. Beck andC.M. Pearson,Freund's Adjuvants: Relationship of Arthrogenicity and Adjuvanticity in Rats to Vehicle Composition, Immunology27, 311–330 (1974).

    PubMed  Google Scholar 

  15. H.U. Bergemyer,Methoden der Enzymatischen Analyse (Verlag-Chemie, Weinheim 1970).

    Google Scholar 

  16. M. Simikoriyama,The Formation of Partial Acetates of Flavones, Flavonones Anthraquinones and Similar Compounds, Bull. Chem. Soc. Jap.16, 284–291 (1941).

    Google Scholar 

  17. F.D. Chattaway,Acetylation in Aqueous Alkaline Solutions, J. Chem. Soc.1931, 2495–2496 (1931).

    Article  Google Scholar 

  18. M.A. Stahmann, I. Wolff andK.P. Link,Studies on 4-Hydroxy-Coumarins. I. The Sythesis of 4-Hydroxy-Coumarins, J. Am. Chem. Soc.65, 2285–2287 (1943).

    Article  Google Scholar 

  19. C.H. Morris, J.E. Christian, R.R. Landolt andW.G. Hanson,Metabolism of Aspirin in Rumen and Corpus Tissues of Rat Stomach During the First Four Minutes After Administration, J. Pharm., Sci.62, 1017–1018 (1973).

    Google Scholar 

  20. K.D. Rainsford,The Biological Pathology of Aspirin-Induced Gastric Damage, Agents and Actions5, 326–344 (1975).

    PubMed  Google Scholar 

  21. R. Kumar andJ.D. Ballimora,Gastric Ulceration and the Content of Salicylates in Plasma in Rats after Administration of 14 C-labelled Aspirin and its synthetic triglyceride, 1,3-Dipalmitoyl-2(2′-acetoxy-( 14 C)-carboxyl benzoyl)glycol, J. Pharm. Pharmac.30, 754 (1978).

    Google Scholar 

  22. M.W. Whitehouse, K.D. Rainsford, N.G. Ardlie, I.G. Young andK. Brune,Alteratives to Aspirin Derived from Biological Sources, in:Aspirin and Related Drugs: Their Actions and Uses (Eds. K.D. Rainsford, K. Brune and M.W. Whitehouse; Agents and Actions Suppl. 1, Birkhäuser, Basel 1977), pp. 43–57.

    Google Scholar 

  23. K.D. Rainsford, A. Schweitzer, P. Green, K. Brune andM.W. Whitehouse,Distribution of Salicylates with Low Gastric Ulcerogenic Activity, Agents and Actions10, 457–464 (1980).

    PubMed  Google Scholar 

  24. R.D. Sofia, W. Diamantis andB.J. Ludwig,Comparative Anti-Inflammatory, Analgesic and Anti-Pyretic Activities of 7-Chloro-3,3a-dihydro-2-methyl-2H, 9H-isoxazolo-(3,2b)(1,3)-benzoxazin-9-one and 5-Chlorosalicylic Acid in Rats, J. Pharm. Sci.64, 1321–1324 (1975).

    PubMed  Google Scholar 

  25. I.N. Rabboniwicz, P.L. Wolf andS. Berman,Light Scattering Studies of Retardation of Sickling by Aspirin-Like Drugs, Res. Comm. Chem. Pathol. Pharmac.8, 417–420 (1974).

    Google Scholar 

  26. J.A. Walder, R.H. Zaugg, R.S. Iwoaka, W.G. Watkin andI.M. Klotz,Alternative Aspirins as Antisickling Agents: Acetyl-3,5-dibromoaspirin, Proc. Nat. Acad. Soc.74, 5499–5503 (1977).

    Google Scholar 

  27. K.D. Rainsford andK. Brune,Role of the Parietal Cell in Gastric Damage Induced by Aspirin and Related Drugs: Implications for Safer Therapy, Med. J. Aust.1, 881–883 (1976).

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rainsford, K.D., Whitehouse, M.W. Anti-inflammatory/anti-pyretic salicylic acid esters with low gastric ulcerogenic activity. Agents and Actions 10, 451–456 (1980). https://doi.org/10.1007/BF01968046

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01968046

Keywords

Navigation